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Abstract 
There is limited clinical experience with left ventricular assist device therapy in 
patients with prosthetic mitral valves. We present a case of successful left 
ventricular assist device support in a patient with previous mechanical mitral 
valve replacement. 
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The approach to the patient with a mechanical mitral valve replacement (MVR) 
who requires left ventricular assist device (LVAD) therapy can be problematic. 
There is limited anecdotal experience in the literature on LVAD support in 
patients with mechanical MVR. This case report details successful continuous-
flow LVAD placement in a patient with a Bjork-Shiley MVR.   
 
A 54 year old male patient with nonischemic cardiomyopathy who was actively 
listed for heart transplantation presented for consideration of left ventricular 
assist device (LVAD) therapy due to worsening heart failure. His history was 
significant for severe mitral regurgitation which required mechanical Bjork-Shiley 
mitral valve replacement (MVR) at 19 years of age. The patient did well after 
MVR but subsequently developed systolic heart failure years later which was 
idiopathic in nature. The patient had been on intravenous milrinone for 12 months 
and listed for transplant as a status 1B. Due to worsening heart failure, he was 
admitted to the hospital and his status changed to 1A. However, the patient 
continued to worsen and no donor organ was available. We made the decision to 
proceed with implantation of HeartMate II LVAD (Thoratec Corporation, 
Pleasanton, CA).  Perioperative course was uneventful other than bleeding which 
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was expected. Low-dose intravenous heparin and warfarin were started on post-
operative day #1. The patient was discharged on post-operative day #21.  
Hospitalization was extended by the presence of right ventricular dysfunction 
which subsequently resolved. Subsequent follow-up has demonstrated normal 
functioning MVR and normal flows through LVAD which is set at 9200 RPM 
(Figure 1). Laboratory testing reveals slight elevation of total bilirubin (1.4 – 1.8 
mg/dL) and LDH (300-600 U/L) likely indicating low level of hemolysis from MVR.  
We have maintained target INR 2.5-3.5 and the patient has not had any major 
bleeding complications. The patient has done well through 1295 days of follow-
up.   
 
This case demonstrates that prior mechanical MVR is not a contraindication to 
LVAD placement and that such patients can do well with long-term continuous-
flow LVAD support. Ideally heart transplantation would be the best option if a 
patient with a prosthetic MVR and severe heart failure is a candidate for 
transplantation. However, given longer wait times for transplantation and scarcity 
of donor organs, LVAD will need to be considered for such patients. Concerns 
with the presence of a mechanical MVR in LVAD patients include perioperative 
anticoagulation, the potential increased risk for thromboembolism, and higher 
target INR which may increase the risk of gastrointestinal bleeding.  The Bjork-
Shiley MVR is believed to have a higher rate of thrombosis than other prosthetic 
MVR which was a particular concern for our patient (1). Fortunately our patient 
has done well with long-term support.   
 
Goda et. al. (2) published the largest series describing 9 patients with mechanical 
MVR undergoing LVAD implantation. The majority of these patients were 
supported with HeartMate XVE device – 3 had HeartMate II LVAD.   The patients 
did well with LVAD support with the majority undergoing heart transplantation. 
The longest duration of support reported in these 9 patients was 507 days. 
Swartz et. al. (3) reported on VAD support on 2 patients with Bjork-Shiley MVR, 
but they were supported with temporary pumps and the duration of support was 
quite short (3 and 12 days). Other case series in the literature report on very few 
patients with mechanical MVR with the majority of patients having prosthetic 
valves in the aortic position (4, 5). Our case report represents the longest 
reported duration of LVAD support on a mechanical MVR.   
 
Given improving outcomes with LVAD technology and the limitations of organ 
transplantation, it is possible that LVAD candidates with mechanical valves may 
become more common in the future. While a great deal of interest has focused 
on valves in the aortic position, there is little data or guidance for the approach to 
LVAD in patients with prosthetic mitral valves (6). This case report demonstrates 
that LVAD patients with mechanical MVR, particularly one as potentially 
thrombogenic as the Bjork-Shiley valve, can have successful outcomes. The 
presence of a mechanical MVR is not an absolute contraindication for long-term 
LVAD support. 
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Four-chamber video clip of color Doppler flow through MVR towards LVAD 
cannula in left ventricular apex (https://vimeo.com/120809245).   
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